Address

RM Global Partners
New York, NY 00000
United States

Open map

Tags
KANDO id: 1033301

Corporate information

Registration country

Company type

Venture capital fund that invests in innovative, early stage biopharma assets, through its partnership with FutuRx.

Overview

RMGP Biopharma Investment Fund is a Venture Capital (VC) Fund that invests in innovative, early stage biopharma assets, through its partnership with FutuRx. FutuRx is an Israel-based, globally focused drug development platform, founded by Orbimed, Johnson&Johnson and Takeda. RMGP's partnership with the incubator provides access to projects carefully selected by industry professionals, with potential to be first-in-class or best-in-class treatments for therapeutic areas with high unmet need (e.g.: oncology, rare diseases, autoimmune diseases, cardiovascular and metabolic diseases, neurodegenerative and other CNS disorders)

Funding rounds

Investment preferences

Investment focus themes

Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Funding
GliXogen Developer of treatment to enhance remyelination in neurodegenerative disorders. Seed

Current team

Past employees

Selected Products / Customers

Financials